DCT

1:20-cv-01426

Novartis Pharma Corp v. Aurobindo Pharma Ltd

General

Filed

10/23/20

Cause of ActionInfringement

SectorBiotech

StatusClosed

Patent Owner

Operating Company

PACER1:20-cv-01426

Nature of Suit835 ANDA

CourtD. Delaware

Judge	Period	PO Win Rate
Maryellen Noreika	--	45%

Plaintiff

Party

Name	Ratings
Novartis Pharmaceuticals Corp	L4A

Attorney

Name	Ratings
McCarter & English LLP	L4A
Daniel M. Silver	L5A
Alexandra M. Joyce	L3B
Williams & Connolly LLP	L3B
Bruce R. Genderson	L5A
Dov P. Grossman	L5A
Christopher J. Mandernach	L5B
Jessamyn S. Berniker	L5C
Kevin Hoagland-Hanson	L3C
Sarahi Uribe	L2C
Michael Xun Liu	---- --
Kathryn E. Garza	---- --
Tian Huang	---- --

Defendant

Party

Name	Ratings
Aurobindo Pharma USA Inc	L4E
Micro Labs USA Inc	L2E

Attorney

Name	Ratings
Morris James LLPLocal	L4E
Kenneth L. Dorsney	L4E
Cortlan Hitch	L1B
Phillips Goldman McLaughlin & Hall PALocal	L4E
John C. Phillips, Jr.	L5E
Megan C. Haney	L4E
Taft Stettinius & Hollister LLP	L3E
Ian Scott	L5E
Stephen R. Auten	L5E
Philip Y. Kouyoumdjian	L4D
Jaimin H. Shah	L3E
Fisherbroyles LLP	L2E
Gongjun Ji	L5C
Gurpreet S. Walia	L4E
Withers Bergman	L1E
Steven A. Moore	L5A
James E. Nealon	L4E
Attorney at LawLocal	---- --
Lina Genovesi	---- --